home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Regulating Stem Cell Treatments

  October, 1 2009 17:43
your information resource in human molecular genetics

Patients with incurable diseases are increasingly travelling thousands of miles for expensive, but risky and unproven stem-cell procedures. A Commentary in Nature Reports Stem Cells analyzes the efforts that the governments of China, India, Thailand, and the United States have made to curb such practices, and why they often prove ineffective.

Profit-driven practitioners advertise services directly to clients and are increasingly organized into international networks. Though some countries have prosecuted individuals and closed down clinics, many clinics are thriving. In the Commentary, Doug Sipp from the RIKEN Center for Developmental Biology in Japan and Sorapop Kiatpongsan from Harvard and Chulalongkorn University (Bangkok) show how countries fail to stop stem-cell providers from charging patients huge sums to administer unproven treatments, either because appropriate regulations do not exist or are not enforced.

The Commentary will be available online: here.

Author contacts:

Doug Sipp (RIKEN Center for Developmental Biology, Kobe, Japan)
E-mail: sipp@cdb.riken.jp

Sorapop Kiatpongsan (Chulalongkorn University, Bangkok, Thailand)
E-mail: ksorapop@yahoo.com

Abstract available online.

(C) Nature Reports Stem Cells press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.